$64.78
$0.00 (0.00%)
End-of-day quote: 05/04/2024
NasdaqGS:GILD

Gilead Sciences Inc Annual Report

Year Year 2023 2022 2021 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Rev. Revenue
$27.12B $27.28B $27.31B $1.32B $2.03B $3.03B $4.23B $5.34B $7.01B $7.95B $8.39B $9.70B $11.20B $24.89B $32.64B $30.39B $26.11B $22.13B $22.45B $24.69B
GM % Gross Margin %
77.80% 79.26% 79.76% 87.42% 87.17% 85.68% 81.83% 78.87% 77.24% 76.48% 74.67% 74.53% 74.48% 84.78% 87.73% 85.98% 83.26% 78.07% 79.18% 85.05%
OM Operating Margin
36.15% 40.23% 43.70% 47.36% 55.09% 54.30% 51.17% 50.40% 51.08% 49.84% 45.54% 44.31% 40.39% 61.33% 68.00% 59.44% 54.10% 42.02% 41.60% 45.43%
EPS Earnings Per Share
$0.00 $6.72 $7.26 $7.28 $7.09 $6.63 $6.67 $8.84 $11.57 $12.61 $8.09 $2.04 $1.95 $1.93 $1.85 $1.41 $1.03 $0.84 $0.63 $0.42 $0.24
Div. Dividends
$3.00 $2.92 $2.84 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.29 $1.84 $2.08 $2.28 $2.52 $2.72
PR % Payout Ratio %
44.64% 40.22% 39.01% 0 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.23% 15.90% 23.53% 34.18% 38.01% 38.36%
Sha. Shares
1,246m 1,247m 1,254m 1795.29m 1838.9m 1844.49m 1864.97m 1819.64m 1799.51m 1,604m 1506.21m 1519.16m 1,534m 1,499m 1,422m 1,310m 1,308m 1,282m 1,266m 1,254m
OCF Operating Cash Flow
$8.01B $9.07B $11.38B $507.96M $705.64M $1.22B $1.67B $2.14B $3.08B $2.83B $3.64B $3.20B $3.11B $12.82B $21.25B $17.05B $11.90B $8.40B $9.14B $8.17B
FCF Free Cash Flow
$8.92B $8.34B $10.81B $456.59M $657.69M $1.11B $1.59B $2.03B $2.85B $2.77B $3.51B $2.80B $2.91B $12.26B $19.58B $15.92B $11.31B $7.48B $8.32B $7.52B
FCFS Free Cash Flow Per Share
$5.95 $6.65 $8.60 $0.26 $0.36 $0.61 $0.86 $1.10 $1.58 $1.62 $2.26 $1.85 $1.91 $8.06 $14.00 $12.17 $8.65 $5.76 $6.55 $5.98